| Long-term results of hypofractionated radiation therapy for breast cancer TJ Whelan, JP Pignol, MN Levine, JA Julian, R MacKenzie, S Parpia, ... New England Journal of Medicine 362 (6), 513-520, 2010 | 1935 | 2010 |
| Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy IA Olivotto, TJ Whelan, S Parpia, DH Kim, T Berrang, PT Truong, I Kong, ... Journal of Clinical Oncology 31 (32), 4038-4045, 2013 | 415 | 2013 |
| Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability C Kearon, K de Wit, S Parpia, S Schulman, M Afilalo, A Hirsch, ... New England Journal of Medicine 381 (22), 2125-2134, 2019 | 259 | 2019 |
| PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma JR Perry, JA Julian, NJ Laperriere, W Geerts, G Agnelli, LR Rogers, ... Journal of Thrombosis and Haemostasis 8 (9), 1959-1965, 2010 | 244 | 2010 |
| Randomized trial of decongestive lymphatic therapy for the treatment of lymphedema in women with breast cancer IS Dayes, TJ Whelan, JA Julian, S Parpia, KI Pritchard, DP D'Souza, ... Journal of Clinical Oncology 31 (30), 3758-3763, 2013 | 193 | 2013 |
| d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant TherapyA Cohort Studyd-Dimer Testing to Select Patients With VTE … C Kearon, FA Spencer, D O'keeffe, S Parpia, S Schulman, T Baglin, ... Annals of internal medicine 162 (1), 27-34, 2015 | 176 | 2015 |
| Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized RatiosA Randomized Trial S Schulman, S Parpia, C Stewart, L Rudd-Scott, JA Julian, M Levine Annals of internal medicine 155 (10), 653-659, 2011 | 122 | 2011 |
| Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy AL Bane, TJ Whelan, GR Pond, S Parpia, G Gohla, AW Fyles, JP Pignol, ... Annals of Oncology 25 (5), 992-998, 2014 | 107 | 2014 |
| Selective d-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous ThrombosisA Randomized Trial LA Linkins, SM Bates, E Lang, SR Kahn, JD Douketis, J Julian, S Parpia, ... Annals of internal medicine 158 (2), 93-100, 2013 | 105 | 2013 |
| Predictors of Adverse Cosmetic Outcome in the RAPID Trial: An Exploratory Analysis D Peterson, PT Truong, S Parpia, IA Olivotto, T Berrang, DH Kim, I Kong, ... International Journal of Radiation Oncology* Biology* Physics 91 (5), 968-976, 2015 | 84 | 2015 |
| Improvement in the quality of abstracts in major clinical journals since CONSORT extension for abstracts: A systematic review L Mbuagbaw, M Thabane, T Vanniyasingam, VB Debono, S Kosa, ... Contemporary clinical trials 38 (2), 245-250, 2014 | 78 | 2014 |
| Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External-Beam Radiation Therapy with External-Beam Radiation Therapy Alone in Node-Negative Locally … IS Dayes, S Parpia, J Gilbert, JA Julian, IR Davis, MN Levine, J Sathya International Journal of Radiation Oncology* Biology* Physics, 2017 | 76 | 2017 |
| The prevalence and significance of a short QT interval in 18 825 low-risk individuals including athletes H Dhutia, A Malhotra, S Parpia, V Gabus, G Finocchiaro, G Mellor, ... Br J Sports Med 50 (2), 124-129, 2016 | 74 | 2016 |
| Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis F Khan, T Tritschler, M Kimpton, PS Wells, C Kearon, JI Weitz, HR Büller, ... Annals of internal medicine 174 (10), 1420-1429, 2021 | 63 | 2021 |
| Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism C Kearon, S Parpia, FA Spencer, T Baglin, SM Stevens, KA Bauer, ... Blood 131 (19), 2151-2160, 2018 | 62 | 2018 |
| Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel S Vedantham, SR Kahn, SZ Goldhaber, AJ Comerota, S Parpia, S Meleth, ... Vascular Medicine 21 (4), 400-407, 2016 | 55 | 2016 |
| Long‐term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d‐dimer results; A cohort study C Kearon, S Parpia, FA Spencer, S Schulman, SM Stevens, V Shah, ... Journal of Thrombosis and Haemostasis 17 (7), 1144-1152, 2019 | 49 | 2019 |
| Accuracy and acceptability of wrist-wearable activity-tracking devices: systematic review of the literature F Germini, N Noronha, V Borg Debono, B Abraham Philip, D Pete, ... Journal of medical Internet research 24 (1), e30791, 2022 | 42 | 2022 |
| Acute toxicity and quality of life of hypofractionated radiation therapy for breast cancer J Arsenault, S Parpia, M Goldberg, E Rakovitch, H Reiter, M Doherty, ... International Journal of Radiation Oncology* Biology* Physics 107 (5), 943-948, 2020 | 42 | 2020 |
| Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic … MJ Clemons, B Cochrane, GR Pond, N Califaretti, SKL Chia, RA Dent, ... Breast cancer research and treatment 146, 153-162, 2014 | 42 | 2014 |
Jim JulianMcMaster UniversityVerified email at mcmaster.ca
